{{Rsnum
|rsid=11134527
|Gene=SLIT3
|Chromosome=5
|position=168768351
|Orientation=plus
|GMAF=0.3274
|Gene_s=MIR218-2,SLIT3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.6 | 33.8 | 61.5
| HCB | 37.8 | 51.1 | 11.1
| JPT | 35.6 | 35.6 | 28.9
| YRI | 0.0 | 17.5 | 82.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 37.8 | 51.1 | 11.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20163849
|Title=Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women
}}

{{PMID Auto
|PMID=22011248
|Title=Association Between pri-miR-218 Polymorphism and Risk of Hepatocellular Carcinoma in a Han Chinese Population
}}

{{PMID Auto
|PMID=23566829
|Title=No Association of Functional Variant in pri-miR-218 and Risk of Congenital Heart Disease in a Chinese Population
}}

{{PMID Auto
|PMID=24761857
|Title=Association Between the Pre-mir-218 Polymorphism and Cancer Risk in the Chinese Population: a Meta-Analysis
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}